What Фемилекс Treats: Main Uses and Benefits

This medication is applied across domains where additional symptomatic support is needed for clinical presentations associated with a disturbed vaginal flora, including symptomatic episodes of Bacterial Vaginosis (BV) and general states of pH imbalance. Lactic Acid preparations are commonly used across conditions presenting with acute episodes and recurrent manifestations.

Фемилекс supports the management of symptoms that interfere with daily functioning, including symptoms related to abnormal vaginal discharge and unpleasant vaginal odor. It is relevant for easing symptoms related to inflammatory or irritative states and episodic changes in situations involving recurrent flora disturbance, post-antibiotic therapy, and general pH imbalance. Helping to ease these symptoms contributes to improved comfort during periods of heightened symptoms, which assists with maintaining functional stability when symptoms become more noticeable.

Clinical Context: Symptom Management
This therapeutic approach is commonly used to help with symptom clusters that may become intense or disruptive, and is applied across therapeutic domains that involve heightened symptom manifestations.

The product is also relevant in settings where the therapeutic goal is applied in situations involving recurrent or episodic manifestations, offering supportive relief that assists with managing recurrent or episodic manifestations and supports general well-being during symptomatic phases.

Regulatory References

1. NHS Clinical Guidance on Bacterial Vaginosis

The eligibility profile for Фемилекс (Lactic Acid vaginal suppositories) is defined by a set of strict contraindications and age restrictions documented in official regulatory instructions. Use of this medicine is formally permitted only for adult females, 18 years of age and older.

---

Eligibility Scope

Category	Official Regulatory Statement
Allowed Population	Adult females, 18 years of age and older.
Contraindicated Groups	Individuals with known hypersensitivity to Lactic Acid or any of the suppository components.
Age Restriction	Use is contraindicated in children and adolescents under 18 years of age.
Clinical Exclusion	Contraindicated for patients with Candidal Vulvovaginitis (Vaginal Thrush).
Reproductive Status	Use is contraindicated during both pregnancy and the period of lactation (breastfeeding).

---

Resulting Eligibility Structure

These regulatory constraints define the mandatory boundaries for product use. The official eligibility profile establishes absolute non-eligibility based on specific local pathology (Candidal Vulvovaginitis) and physiological state, limiting the allowed population to those who meet the minimum age requirement and possess none of the listed contraindications. No specific restrictions related to renal or hepatic impairment are documented in the official regulatory sections.

Interactions with other medicines and products

The interaction profile for Lactic Acid (Фемилекс) is determined by its localized effect in the vaginal environment and its minimal systemic exposure. Regulatory documentation focuses primarily on local pharmacodynamic and administration-timing constraints rather than metabolic drug-drug interactions.

Local Co-administration and Restrictions Co-administration with other intravaginal products is subject to specific regulatory constraints. The use of Lactic Acid preparations is formally restricted when combined with vaginal contraceptive rings. This restriction is based on the potential for interference within the local environment. Conversely, official labeling confirms the product's compatibility for simultaneous use with the vaginal formulations of certain anti-infective agents, specifically Miconazole, Metronidazole, and Tioconazole.

Pharmacokinetic Considerations Official regulatory reviews confirm that the active substance, Lactic Acid, is not associated with documented systemic pharmacokinetic interactions. Systemic exposure following intravaginal administration is not deemed significant enough to mediate clinically relevant effects on drug-metabolizing enzymes, such as Cytochrome P450, or major drug transporters. Therefore, no classic interactions altering the clearance or systemic levels of co-administered oral medicines are formally noted in official prescribing information.

Timing and General Constraints A general constraint advises caution against co-administration with other intravaginal products not explicitly listed as compatible, as the potential exists for altering the release or absorption characteristics of the co-administered drug. No specific interaction data is documented regarding food, alcohol, or herbal products for this localized formulation.

Direct pH Modulation

This domain describes the direct biochemical action of lactic acid on the local environment. It initiates a rapid pH reduction, shifting the environment toward its physiologically acidic range (around 3.5 to 4.5). The resulting pH value is below the growth optima for many common bacterial and fungal species. This rapid chemical adjustment creates a selective environment that influences microbial population dynamics.

Support of Lactobacillus Population Dynamics

The mechanism also engages with the process of microbial population selection. The creation of a low-pH environment provides conditions that favor the proliferation and colonization of resident Lactobacillus species. The acidic environment allows Lactobacillus populations to increase relative to other local microbial populations. This shifts the microbial balance, impacting subsequent metabolic and pH-modulating activity within the microflora.

Official Administration Guidelines

Administration of Фемилекс is based on the proper use protocols for its official dosage form, which is a vaginal suppository, typically supplied in a 100 mg strength. Standard guidelines define the exact procedure and schedule required for use.

Dosing and Schedule

Administration Scope	Official Requirement
Route	Intravaginal (Vaginal)
Dosing Schedule	One suppository per day
Frequency	Once daily (Q.D.)
Timing	Preferably at bedtime

Procedural Requirements

The proper administration method requires the user to follow specific steps to ensure the correct placement and retention of the medicine in the vaginal canal.

1. Preparation: Hands must be washed thoroughly with soap and water immediately before handling and unwrapping the suppository.
2. Positioning: The suppository should be inserted while lying on the back with knees bent or while standing with one foot elevated, whichever is most comfortable.
3. Insertion: The suppository is gently pushed as far into the vagina as comfortable, using an applicator if provided, or a clean finger.
4. Retention: After insertion, the user should remain lying down for a recommended period (e.g., 10 to 15 minutes) to allow the suppository to melt and minimize leakage.

Administration must continue daily for the full course duration specified by the healthcare provider, and the regimen should be followed even during menstruation. If a dose is missed, it should be administered as soon as the omission is realized, unless it is nearly time for the next scheduled dose, in which case the regular schedule is resumed without doubling the quantity.

Recent Clinical Evidence Overview

Фемилекс (Femilex) is a vaginal suppository drug whose active ingredient is Lactic Acid. This substance is classified as an antacid/antiseptic agent and is used primarily to help restore the normal pH and microflora balance of the vaginal environment.

Since Lactic Acid is a naturally occurring organic compound commonly used in over-the-counter products to maintain vaginal health, formal clinical trials (such as large-scale randomized controlled trials for efficacy and safety, typical for new chemical entities) are generally not the focus of current research for this specific product. Research is instead often directed toward the use of Lactic Acid-containing preparations in specific clinical contexts.

Research Focus Areas

• Bacterial Vaginosis (BV) Management: Studies have investigated the use of Lactic Acid preparations, including vaginal suppositories, in conjunction with or following standard antibiotic therapy for bacterial vaginosis. The aim of this research is to evaluate if Lactic Acid, by creating an acidic environment (low pH), can help prevent the recurrence of BV, which is a common challenge for patients.
• Vaginal pH Restoration: Research consistently demonstrates that the application of Lactic Acid products is associated with a decrease in vaginal pH, helping to create conditions that support the growth of beneficial Lactobacilli bacteria. This restoration of pH is the foundation of the drug's mechanism.
• Long-Term Support: Clinical use and observational data suggest that products supporting a normal vaginal pH may be beneficial for long-term maintenance of the microflora balance, particularly after antibiotic exposure or during hormonal changes. However, ongoing, large-scale studies are limited, and individual patient responses may vary.

Key Studies & References

1. The Role of Lactic Acid in the Management of Bacterial Vaginosis: A Systematic Literature Review
2. 2018 European (IUSTI/WHO) Guideline on the Management of Vaginal Discharge (Used for context on standard treatment and BV recurrence)

Common questions about Фемилекс (FAQ)

Q: What is the purpose of Фемилекс?

According to the official product information, Фемилекс is indicated for the topical treatment of bacterial vaginosis. It is also used as part of the combined therapy for non-specific (non-infectious) vaginitis. Its primary purpose, as stated in regulatory documents, is to help restore the normal pH and microflora of the vagina.

Q: Does Фемилекс contain an antibiotic?

No, Фемилекс does not contain an antibiotic. The active component is lactic acid, a substance naturally present in the body. Regulatory documents state that the medicine works by restoring the acidic pH of the vagina, which helps create conditions favorable for the growth of normal lactobacilli and suppresses the growth of pathogenic (disease-causing) microflora.

Q: What should I do if I forget to use a dose of Фемилекс?

Official product guidelines indicate that if a dose is missed, the suppository is typically used as soon as the patient remembers. Following this, continuation of the regular treatment schedule is generally advised. The product information states that using a double dose to compensate for a missed one is not recommended.

Q: Is it normal to see some discharge or residue after using the suppositories?

According to the official product information, experiencing some vaginal discharge after using the suppositories is considered normal. The suppository base melts at body temperature, and some residue may naturally exit the vagina. Regulatory sources generally indicate that this residue is not expected to compromise the overall effectiveness of the treatment.

Q: Can Фемилекс be used during menstruation (a period)?

The official product information indicates that the use of Фемилекс is generally recommended to be interrupted during menstruation. Treatment can be resumed after the menstrual period has ended. The importance of completing the prescribed course of treatment is emphasized in the product information to ensure the best results.

Q: Is it possible to use the medicine for a longer time than the doctor advised?

Regulatory documents state that the duration of treatment is typically specified for specific conditions, such as for seven to ten days for bacterial vaginosis. The regulatory documents stress the importance of following the duration of treatment specified by the healthcare provider. Using the medicine for a longer period than advised is not generally recommended and may require re-evaluation by a professional.

How to Store and Dispose of Фемилекс?

The stability and integrity of Фемилекс (Lactic Acid vaginal suppositories) depend on strict adherence to official storage and handling instructions.

Storage Requirements

The product must be stored at a controlled room temperature that does not exceed 25 C (77 F). The suppositories require protection from environmental factors and must be kept in a dry place and protected from light. To maintain product integrity and stability until the time of use, Фемилекс must remain in its original container. As is required for all medicines, the product must be kept out of the sight and reach of children.

Disposal Instructions

When discarding unused or expired Фемилекс, the product must not be thrown away with household garbage or poured down the sink or toilet. Disposal must strictly follow the local regulatory requirements established for unused or expired medicinal products.